Kite Pharma to Report Third Quarter 2016 Financial Results on November 9, 2016

Kite Pharma, Inc. (Nasdaq:KITE) today announced that it will report third quarter 2016 financial results on Wednesday, November 9, 2016, prior to the open of the market. The announcement will be followed by a
live audio webcast and conference call at 8:30 a.m. Pacific Time/11:30 a.m. Eastern Time.
Audio Webcast
The webcast will be made available on the Company’s website at www.kitepharma.com under
the Investors tab in the Events and Presentations section. Following the
live audio webcast, a replay will be available on the Company’s website
for approximately 30 days.
Dial-In Information
Live (U.S. / Canada): 1 (888) 771-4371
Live
(International): 1 (847) 585-4405
Confirmation number: 43463182
About Kite Pharma
Kite Pharma, Inc., is a clinical-stage biopharmaceutical company engaged
in the development of novel cancer immunotherapy products, with a
primary focus on engineered autologous cell therapy (eACT™) designed to
restore the immune system’s ability to recognize and eradicate tumors.
Kite is based in Santa Monica, CA. For more information on Kite Pharma,
please visit www.kitepharma.com.
Sign up to follow @KitePharma on Twitter at www.twitter.com/kitepharma.